Oklo Sinks 4% as Truist Slashes Price Target 39% to $31 Ahead of Q3 Earnings
Oklo (OKLO) shares dropped 4% after Truist reduced its price target to $31 from $51, maintaining a Hold rating. This follows similar cuts from Piper Sandler, Barclays, and Citi this week. Analysts expect minimal revenue until 2028, with Oklo's stock performance tied to future reactor success. NuScale Power (SMR) also fell 2% amid broader market declines and bearish analyst sentiment.
How this was made
The 30-second read
Why it matters
Analyst target cuts signal heightened skepticism, likely extending the recent share sell‑off.
Market read
Both stocks experienced immediate price declines, reflecting the market's reaction to the new analyst guidance.
What to watch
Potential future cash‑flow from upcoming reactor contracts not yet reflected in analyst models.
Background
Oklo and NuScale Power are early‑stage nuclear‑reactor developers with minimal revenue, heavily dependent on future commercial contracts.
Ticker impact
Truist cut OKLO's price target to $31 from $51, causing a 4% share decline ahead of Q3 earnings.
downward pressure as the market prices in the target cut
Four analysts have cut targets in four days, indicating deteriorating sentiment and near-term downside.
Citi and Barclays cut SMR's target and downgraded the stock, contributing to a 2% decline alongside OKLO.
downward pressure as analysts signal weaker outlook
Analyst downgrades and target reductions reflect concerns over commercial contract delays.
Market effects
Nuclear and AI‑power stocks face broader pressure as higher rates and policy uncertainty weigh on renewables.
U.S. small‑cap and clean‑energy segments may see modest pullback.
Limited to investors tracking nuclear tech and clean‑energy equities.
Counterpoint
If the market overreacts, the price dip could present a short‑term buying opportunity on valuation grounds.
Key entities
- AnalystTruist
Hold rating, target cut to $31.
- AnalystCiti
Target cut to $33 for OKLO, $4 for SMR.
